[1]
Fishbane S, Spinowitz BS, Wisemandle WA, Martin NE. Randomized Controlled Trial of Subcutaneous Epoetin Alfa-epbx Versus Epoetin Alfa in End-Stage Kidney Disease. Kidney international reports. 2019 Sep:4(9):1235-1247. doi: 10.1016/j.ekir.2019.05.010. Epub 2019 May 22
[PubMed PMID: 31517143]
Level 1 (high-level) evidence
[2]
Ikunaiye NY, Denue BA, Aina BA, Aderemi-Williams R, Rawizza HE. INCIDENCE OF ANAEMIA AMONG HIV-INFECTED PATIENTS TREATED WITH ZIDOVUDINE-CONTAINING ANTIRETROVIRAL THERAPY IN NORTHEASTERN NIGERIA. Annals of Ibadan postgraduate medicine. 2018 Dec:16(2):115-124
[PubMed PMID: 31217768]
[3]
Ferri RS, Adinolfi A, Orsi AJ, Sterken DJ, Keruly JC, Davis S, MacIntyre RC, Nursing Guidelines Committee for Anemia in Patients with HIv Infection. Treatment of anemia in patients with HIV Infection--Part 2: guidelines for management of anemia. The Journal of the Association of Nurses in AIDS Care : JANAC. 2002 Jan-Feb:13(1):50-9
[PubMed PMID: 11828859]
[4]
Bohlius J, Bohlke K, Castelli R, Djulbegovic B, Lustberg MB, Martino M, Mountzios G, Peswani N, Porter L, Tanaka TN, Trifirò G, Yang H, Lazo-Langner A. Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO/ASH Clinical Practice Guideline Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2019 May 20:37(15):1336-1351. doi: 10.1200/JCO.18.02142. Epub 2019 Apr 10
[PubMed PMID: 30969847]
Level 1 (high-level) evidence
[5]
Joseph SA Jr, Berekashvili K, Mariller MM, Rivlin M, Sharma K, Casden A, Bitan F, Kuflik P, Neuwirth M. Blood conservation techniques in spinal deformity surgery: a retrospective review of patients refusing blood transfusion. Spine. 2008 Oct 1:33(21):2310-5. doi: 10.1097/BRS.0b013e31818047f2. Epub
[PubMed PMID: 18827697]
Level 2 (mid-level) evidence
[6]
Beliaev AM, Allen SJ, Milsom P, Nand P, Smith WM, Bergin CJ. Low-dose erythropoietin treatment is not associated with clinical benefits in severely anaemic Jehovah's Witnesses: a plea for a change. Blood transfusion = Trasfusione del sangue. 2018 Jan:16(1):53-62. doi: 10.2450/2016.0085-16. Epub 2016 Nov 15
[PubMed PMID: 27893353]
[7]
Stickel F, Helbling B, Heim M, Geier A, Hirschi C, Terziroli B, Wehr K, De Gottardi A, Negro F, Gerlach T. Critical review of the use of erythropoietin in the treatment of anaemia during therapy for chronic hepatitis C. Journal of viral hepatitis. 2012 Feb:19(2):77-87. doi: 10.1111/j.1365-2893.2011.01527.x. Epub 2011 Oct 18
[PubMed PMID: 22239497]
[8]
Gascón P, Krendyukov A, Mathieson N, Aapro M. Epoetin alfa for the treatment of myelodysplastic syndrome-related anemia: A review of clinical data, clinical guidelines, and treatment protocols. Leukemia research. 2019 Jun:81():35-42. doi: 10.1016/j.leukres.2019.03.006. Epub 2019 Mar 27
[PubMed PMID: 31005849]
[9]
Moura ATG, Duarte FB, Barbosa MC, Santos TEJD, Lemes RPG. Prolonged response to recombinant human erythropoietin treatment in patients with myelodysplastic syndrome at a single referral centre in Brazil. Clinics (Sao Paulo, Brazil). 2019:74():e771. doi: 10.6061/clinics/2019/e771. Epub 2019 Sep 9
[PubMed PMID: 31508719]
[10]
Saleh MI, Nalbant D, Widness JA, Veng-Pedersen P. Population pharmacodynamic analysis of erythropoiesis in preterm infants for determining the anemia treatment potential of erythropoietin. American journal of physiology. Regulatory, integrative and comparative physiology. 2013 May 1:304(9):R772-81. doi: 10.1152/ajpregu.00173.2012. Epub 2013 Mar 13
[PubMed PMID: 23485870]
Level 2 (mid-level) evidence
[11]
. Hematologic Growth Factors. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. 2012:():
[PubMed PMID: 31644052]
[12]
Brown MS, Jones MA, Ohls RK, Christensen RD. Single-dose pharmacokinetics of recombinant human erythropoietin in preterm infants after intravenous and subcutaneous administration. The Journal of pediatrics. 1993 Apr:122(4):655-7
[PubMed PMID: 8463922]
[13]
Ohls RK, Christensen RD. Stability of human recombinant epoetin alfa in commonly used neonatal intravenous solutions. The Annals of pharmacotherapy. 1996 May:30(5):466-8
[PubMed PMID: 8740324]
[14]
Centers for Disease Control (CDC). Neonatal deaths associated with use of benzyl alcohol--United States. MMWR. Morbidity and mortality weekly report. 1982 Jun 11:31(22):290-1
[PubMed PMID: 6810084]
[15]
Hoffman RS, Cobrin G, Nelson LS, Howland MA. Erythropoietin overdose treated with emergent erythropheresis. Veterinary and human toxicology. 2002 Jun:44(3):157-9
[PubMed PMID: 12046968]
[16]
Provenzano R, Bhaduri S, Singh AK, PROMPT Study Group. Extended epoetin alfa dosing as maintenance treatment for the anemia of chronic kidney disease: the PROMPT study. Clinical nephrology. 2005 Aug:64(2):113-23
[PubMed PMID: 16114787]